Why the study?
Does hesperidin or rutin attenuate cisplatin-induced nephrotoxicity in male rats?
Does hesperidin or rutin attenuate cisplatin-induced nephrotoxicity in male rats?
Hesperidin and rutin demonstrate protective effects against cisplatin-induced nephrotoxicity in a rat model by reducing oxidative stress and improving kidney function.
No change to practice warranted; leaves open translation of hesperidin/rutin renoprotection to cisplatin-treated patients.
This study aimed to assess the protective effect of hesperidin (HES) and rutin (RUT) against cisplatin-induced nephrotoxicity in male rats. Cisplatin (5 mg/kg, intraperitoneal) caused significant increases in serum sodium, blood urea nitrogen, serum creatinine, total sodium and potassium excreted in urine, urine volume, and lipid peroxides measured as the malondialdehyde content of kidney, with significant decreases in serum total protein, creatinine clearance, reduced glutathione content of kidney, and kidney superoxide dismutase activity as compared with the control group. On the other hand, administration of HES (200 mg/kg, per oral [p.o.]) or RUT (30 mg/kg, p.o.) for 14 days with a single cisplatin dose on the tenth day ameliorated the cisplatin-induced nephrotoxicity as indicated by the restoration of kidney function and oxidative stress biomarkers. Furthermore, the test drugs reduced the histopathological changes induced by cisplatin. In conclusion, HES and RUT showed protective effects against cisplatin-induced nephrotoxicity.
No takes yet. Share an insight, caveat, or question.
Kamel et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: